Jenburkt Pharmaceuticals Share Price

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year.